Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,871 | -2,742 | -12,494 | -9,892 | -7,004 |
| Depreciation Amortization | 72 | 36 | 182 | 143 | 100 |
| Accounts payable and accrued liabilities | 494 | -32 | 690 | 959 | 578 |
| Other Working Capital | 930 | 343 | 3,289 | 2,819 | 1,758 |
| Other Operating Activity | 558 | 663 | 2,409 | 2,119 | 1,659 |
| Operating Cash Flow | $-3,815 | $-1,733 | $-5,925 | $-3,851 | $-2,910 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,000 | -5,000 | N/A | N/A | N/A |
| Common Stock Issued | 4,517 | 3,151 | 14,895 | 13,547 | 1 |
| Common Stock Repurchased | -252 | -252 | -173 | N/A | N/A |
| Financing Cash Flow | $-735 | $-2,101 | $14,722 | $13,547 | $1 |
| Exchange Rate Effect | -3 | -1 | -13 | 9 | 14 |
| Beginning Cash Position | 13,360 | 13,360 | 4,577 | 4,577 | 4,577 |
| End Cash Position | 8,807 | 9,526 | 13,360 | 14,281 | 1,682 |
| Net Cash Flow | $-4,553 | $-3,835 | $8,783 | $9,704 | $-2,895 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,815 | -1,733 | -5,925 | -3,851 | -2,910 |
| Free Cash Flow | -3,815 | -1,733 | -5,925 | -3,851 | -2,910 |